// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "disease REQUIRES PATCH YAML IMPORTANT IS TA COULD SH ancestry category HTML individual MS:1001251 BMC DJ label EM PSI QY exclamation biological replicate NCIT:C25683 THE MHC SHOULD PRIDE:0000832 PTM PEPTIDESEQ PRIDE:0000831 HEREIN SILAC SAMN source name proteomics data acquisition method PRIDE:0000833 REQUIRED ZFA PRIDE NCI HUPO cleavage agent details PRIDE:0000834 CID VK INFORMATION PS TMT XML TIP CL COLUMN organism part EXPRESS INCLUDING depletion RECOMMENDED BRENDA PMCID FOR CS ENVO MERCHANTABILITY pooled sample MC CF README sex characteristics NT IAA IDF HANCESTRO ... NCIT:C25714 NCIT HF LC MT not ROW UBERON technical replicate XL BUT URL fractionation method FDR MINOR WILL fraction identifier EW PP MS STANDARDS PO DTT DIA PATO:0000461 AND RFC III WARRANTY OPTIONAL organism biosample accession number PRM LIMITED MIAPE age FAIR PATO THAT RIGHTS CT data file TO mass CELL MONDO SP dissociation method HLA NCBI PROTEOMICS HCD INFRINGE CV PMID reduction reagent MOD USE spiked compound file your DDA NCE LI SAMEA SHALL URI EFO TAB ISA BTO developmental stage OF NOT SN SRM RAW EBI WARRANTIES sample BE OR PARTICULAR RECOMMEND MUST II MIAME IMPLIED ALL MAJOR SDRF NOTE PRIDE:0000659 alkylation reagent AS INITIATIVE AC ID CN FITNESS PURPOSE CPTAC cell type MAGE MAY DISCLAIMS ANY SWATH collision energy CLO VCF instrument JA"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "disease REQUIRES PATCH YAML IS TA COULD SH HTML individual MS:1001251 BMC DJ label EM PSI QY biological replicate NCIT:C25683 THE MHC SHOULD PRIDE:0000832 PTM PEPTIDESEQ PRIDE:0000831 HEREIN SILAC SAMN proteomics data acquisition method PRIDE:0000833 REQUIRED ZFA PRIDE NCI HUPO cleavage agent details PRIDE:0000834 CID VK INFORMATION PS TMT CL COLUMN organism part EXPRESS INCLUDING depletion RECOMMENDED BRENDA PMCID FOR CS ENVO MERCHANTABILITY pooled sample MC CF README NT IAA IDF HANCESTRO ... NCIT:C25714 NCIT HF LC MT ROW UBERON technical replicate XL BUT URL fractionation method FDR MINOR WILL fraction identifier EW PP MS STANDARDS PO DTT DIA PATO:0000461 AND RFC III WARRANTY OPTIONAL organism biosample accession number PRM LIMITED MIAPE age FAIR PATO THAT RIGHTS CT data file TO mass CELL MONDO SP dissociation method HLA NCBI PROTEOMICS HCD INFRINGE CV PMID reduction reagent MOD USE spiked compound DDA NCE LI SAMEA SHALL URI EFO TAB ISA BTO OF NOT SN SRM RAW EBI WARRANTIES BE OR PARTICULAR RECOMMEND MUST II MIAME IMPLIED ALL MAJOR SDRF PRIDE:0000659 alkylation reagent AS INITIATIVE AC CN PURPOSE FITNESS cell type CPTAC MAGE MAY DISCLAIMS ANY SWATH collision energy CLO VCF instrument JA"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "disease developmental stage UBERON:0002107 APP MONDO:0004975 PO CL organism part PATO:0000461 enrichment process MONDO:0004989 depletion organism exclamation MUST xenograft CL:0000815 age DOID PATO PTM MONDO SDRF NOTE MONDO:0005148 NCBI PDX CL:0000066 PATO:0001421 CL:0000624 synthetic peptide CL:0000084 ID cell type MAY UBERON UBERON:0000178 EFO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "disease developmental stage UBERON:0002107 APP MONDO:0004975 PO CL organism part PATO:0000461 enrichment process MONDO:0004989 depletion organism MUST xenograft CL:0000815 age DOID PATO PTM MONDO SDRF MONDO:0005148 NCBI PDX CL:0000066 PATO:0001421 CL:0000624 synthetic peptide CL:0000084 ID cell type MAY UBERON UBERON:0000178 EFO"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "TNM IMPORTANT AJCC CHEBI:28748 organism part sampling time point NCIT:C18206 ancestry category TNM staging treatment response HIPAA individual treatment menopausal status pre-existing condition exclamation NCIT:C27966 tumor grade NCIT:C28078 weight IV HANCESTRO:0009 NCIT:C65106 MONDO SDRF NCIT:C65107 Ann Arbor stage MONDO:0005044 MONDO:0005148 dose treatment status Dukes stage NCIT:C27971 smoking status GDPR NCIT:C53554 PR body mass index ER NCIT:C15632 NCIT:C71732 NCIT NCIT:C4870 HANCESTRO ID HANCESTRO:0005 NCI CHEBI:27899 breast cancer subtype NCIT:C65108 compound NCIT:C15262 disease stage NCIT:C28076"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "TNM AJCC CHEBI:28748 organism part sampling time point NCIT:C18206 ancestry category TNM staging treatment response HIPAA individual treatment menopausal status pre-existing condition NCIT:C27966 tumor grade NCIT:C28078 weight IV HANCESTRO:0009 NCIT:C65106 MONDO SDRF NCIT:C65107 Ann Arbor stage MONDO:0005044 MONDO:0005148 dose treatment status Dukes stage NCIT:C27971 smoking status GDPR NCIT:C53554 PR body mass index ER NCIT:C15632 NCIT:C71732 NCIT NCIT:C4870 HANCESTRO ID HANCESTRO:0005 NCI CHEBI:27899 breast cancer subtype NCIT:C65108 compound NCIT:C15262 disease stage NCIT:C28076"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "TMT TA UNIMOD PP MS fragment mass tolerance DIA scan window lower limit UNIMOD:35 MS:1001251 label PSI exclamation precursor mass tolerance README SDRF SILAC MS:1001309 AC NT REQUIRED PRIDE MS1 scan range MT cleavage agent details modification parameters MOD MS2 analyzer type scan window upper limit UNIMOD:4"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "TMT TA UNIMOD PP MS fragment mass tolerance DIA scan window lower limit UNIMOD:35 MS:1001251 label PSI precursor mass tolerance SDRF SILAC MS:1001309 AC NT REQUIRED PRIDE MS1 scan range MT cleavage agent details modification parameters MOD MS2 analyzer type scan window upper limit UNIMOD:4"
  }
];
